Table 7 Cost differences (€) between pharmacogenomics and non-pharmacogenomics groups per patient
| Â | Emergency unit cost | Hospitalization cost | Follow-up cost | Total cost* |
|---|---|---|---|---|
PGx-guided group | ||||
B-Mean | 117.8 | 574.0 | 70.7 | 882.5 |
B-Stdev | 39.2 | 283.1 | 8.3 | 324.0 |
B-Max | 286.6 | 1877.3 | 103.6 | 2355.7 |
B-Min | 9.3 | 0.0 | 42.9 | 184.4 |
95%UCI | 200.8 | 1187.5 | 88.4 | 1581.8 |
95%LCI | 46.8 | 75.7 | 56.1 | 315.9 |
Control group | ||||
B-Mean | 298.8 | 1367.6 | 89.0 | 1755.4 |
B-Stdev | 115.9 | 462.4 | 32.9 | 556.0 |
B-Max | 865.6 | 3250.1 | 234.2 | 4128.2 |
B-Min | 21.6 | 105.2 | 16.8 | 143.6 |
95%UCI | 564.6 | 2350.2 | 164.4 | 2949.0 |
95%LCI | 115.6 | 554.3 | 36.4 | 765.1 |
Control v/s PGx-guided group | ||||
B-Mean | 181.0 | 793.6 | 18.3 | 872.9 |
B-Stdev | 122.3 | 543.0 | 34.1 | 644.4 |
B-Max | 758.3 | 2887.1 | 159.8 | 3518.4 |
B-Min | − 154.8 | − 1277.4 | − 60.0 | − 1556.0 |
95% UCI | 454.5 | 1914.9 | 95.2 | 2188.7 |
95% LCI | − 24.7 | − 249.0 | − 38.1 | − 356.8 |